With the acquisition of the Swedish company Safe Control Materialteknik i Göteborg AB (Safe Control) GBA Group is expanding its regional presence in Sweden. After successfully entering the pharmaceutical and medical device market there last year, Safe Control meaningfully complements the GBA Group's service portfolio in the area of environmental and material analysis.

Rob Lotthrincx has started as the new Managing Director of ABF Pharmaceutical Services GmbH (ABF) in Vienna on August 1st, 2024.

Dear Rob, it is so great to see that you have been so well received. We are font to have you, your many years of experience as a leader and your profound expertise in pharma logistics and supply chain management on board.

Regulation (EU) 2023/915 is being updated to make the rules on contaminants in food clearer. These adjustments are listed in regulation (EU) 2024/1756. New rules are introduced for testing for certain substances in cereals, baby food and oat products. It also clarifies the rules for maximum amounts of harmful substances in rice products, animal products and cereal products. Below in tabular form is an overview of the changes effective July 16, 2024.

GBA MDS will be represented at the 2nd Annual European Medical Device Biocompatibility Conference! This prestigious event will take place on September 18 and 19, 2024, in Munich and brings together professionals from various companies to discuss the latest developments and challenges in medical device biocompatibility.

The European Commission has expressed its intention with the document SANTE PLAN 2023/2345 Rev.2. to amend Regulation (EU) 2023/915 to regulate maximum levels of Mineral Oil Hydrocarbons (MOH) in food. These draft measures are intended to protect public health from the potential harmful effects of MOH, which can occur in food due to contamination from various sources such as machine lubricants, processing aids and environmental sources.